["Allergy, Intolerance": "ACE Inhibitor or ARB or ARNI Ingredient"]
Performance/Reporting Period
2024
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to represent concepts for medications of angiotensin-converting enzyme (ACE) inhibitor, angiotensin-receptor blocker (ARB), and angiotensin receptor/neprilysin inhibitor (ARNI) ingredients.
Data Element Scope: This value set may use a model element related to Allergy/Intolerance.
Inclusion Criteria: Includes concepts that represent an allergy or intolerance for prescribable angiotensin-converting enzyme (ACE) inhibitor, angiotensin-receptor blocker (ARB), and angiotensin receptor/neprilysin inhibitor (ARNI) ingredients only.
Exclusion Criteria: No exclusions.
Data Element Scope: This value set may use a model element related to Allergy/Intolerance.
Inclusion Criteria: Includes concepts that represent an allergy or intolerance for prescribable angiotensin-converting enzyme (ACE) inhibitor, angiotensin-receptor blocker (ARB), and angiotensin receptor/neprilysin inhibitor (ARNI) ingredients only.
Exclusion Criteria: No exclusions.
Constrained to codes in the ACE Inhibitor or ARB or ARNI Ingredient value set (2.16.840.1.113883.3.526.3.1489)
QDM Datatype and Definition
"Allergy Intolerance"
Data elements that meet criteria using this datatype should document the allergy or intolerance and its corresponding value set.
Timing:
- The prevalencePeriod references the time from the onset date to the abatement date. Often an abatement date is not present as allergy or intolerance is ongoing.
- The author dateTime references the recorded time.
Last Updated: Jun 29, 2023